Stock Market Stories and Insights

<div class='circular--portrait-small' style='font-weight: 700;background:#82ADFD;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>NW</div>
  a day ago at Macroaxis 
By Vlad Skutelnik
As many rational traders are trying to avoid healthcare space, it makes sense to review Neptune Wellness Solutions a little further and understand how it stands against Eagle Pharmaceuticals and other similar entities. We are going to break down some of the competitive aspects of both Neptune and Eagle.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0000;color: #F5FFFA;font-size:1.1em;padding-top: 10px;;'>HM</div>
  a day ago at Macroaxis 
By Achuva Shats
HTG Molecular is currently generating 1.1276% in daily expected returns and assumes 6.5971% risk (volatility on return distribution) over the 90 days horizon. While some of us are excited about healthcare space, it makes sense to summarize HTG Molecular in greater detail to make a better estimate of its risk and reward. We will summarize if the expected returns on HTG Molecular will justify its current volatility. The new HTG Molecular risk factors may impact the value of the stock as we estimate HTG Molecular as currently undervalued. The real value is approaching 0.80 per share.
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;padding-top: 10px;;'>AP</div>
  a day ago at Macroaxis 
By Gabriel Shpitalnik
Aurinia Pharmaceuticals is scheduled to announce its earnings today. The next earnings report is expected on the 12th of November 2020. While many of us are getting excited about healthcare space, we are going to concentrate on the feasibility of locking in Aurinia. We will cover the possibilities of Aurinia Pharmaceuticals recovering given the current economic outlook.
<div class='circular--portrait-small' style='font-weight: 700;background:#754DEB;color: #F0FFF0;font-size:1.1em;padding-top: 10px;;'>AS</div>
  a day ago at Macroaxis 
By Achuva Shats
Avino Silver Book Value per Share is relatively stable at the moment as compared to the past year. The company's current value of Book Value per Share is estimated at 1.03. Current Ratio is expected to hike to 3.18 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (29 M). While some baby boomers are getting worried about basic materials space, it is reasonable to summarize Avino Silver Gold. I will take a closer look at this stock and the new sentiment generated by stakeholders. Here I will also expose some primary fundamental factors affecting Avino Silver's services, and outline how it will impact the outlook for investors this year.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0F00;color: #FFFFF0;font-size:1.1em;padding-top: 10px;;'>AT</div>
  a day ago at Macroaxis 
By Achuva Shats
Agile Therapeutics is scheduled to announce its earnings today. The next earnings report is expected on the 26th of October 2020. As many retail investors are getting excited about healthcare space, it is fair to break down Agile Therapeutics outlook under the current economic conditions. I will address why investors ignored this entity since the beginning of the current economic outlook.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>FT</div>
  a day ago at Macroaxis 
By Raphi Shpitalnik
Fuel Tech is scheduled to announce its earnings today. The next earnings report is expected on the 11th of November 2020. Fuel Tech Enterprise Value is decreasing as compared to previous years. The preceding year's Enterprise Value was reported at 8.74 Million. The current Invested Capital is estimated to increase to about 18 M, while Earnings before Tax are projected to decrease to (8 M). As many passive investors are finally getting excited about industrials space, Fuel Tech could be a good starting point. We will concentrate on if it could be a much better year for Fuel Tech shareholders.
<div class='circular--portrait-small' style='font-weight: 700;background:#006400;color: #FFE4E1;font-size:1.7em;padding-top:4px;;'>I</div>
  a day ago at Macroaxis 
By Ellen Johnson
While some baby boomers are getting worried about technology space, it is reasonable to outline Intellicheck. We will evaluate why recent Intellicheck price moves suggest a bounce in September. Is the firm valuation sustainable? Here I will cover a perspective on valuation of Intellicheck to give you a better outlook on taking a position in this stock.
<div class='circular--portrait-small' style='font-weight: 700;background:#3b5998;color: #F0F8FF;font-size:0.9em;padding-top: 12px;;'>OSP</div>
  2 days ago at Macroaxis 
By Gabriel Shpitalnik
In general, we focus on analyzing OneSpan (NASDAQ:OSPN) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OneSpan daily price indicators and compare them against related drivers. Today's article will outline OneSpan. We will evaluate why we are still confident in anticipation of a recovery.
<div class='circular--portrait-small' style='font-weight: 700;background:#347AFC;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>RR</div>
  2 days ago at Macroaxis 
By Achuva Shats
As many millenniums are trying to avoid consumer cyclical space, it makes sense to go over Red Robin Gourmet a little further and try to understand its current market patterns. As expected, Red Robin is starting to reaffirm its true potential as investors are becoming more and more confident in the future outlook. A lot of the movements of the company stock price movements has been a reflection of what is happening in the market overall. The appearance of strong basic indicators of the company suggests a short-term price swing for investors of Red Robin. Red Robin Gourmet is scheduled to announce its earnings today. The next earnings report is expected on the 3rd of November 2020.
<div class='circular--portrait-small' style='font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;padding-top: 10px;;'>VS</div>
  2 days ago at Macroaxis 
By Raphi Shpitalnik
As many rational traders are trying to avoid technology space, it makes sense to focus on Viavi Solutions a little further and understand how it stands against Cisco Systems and other similar entities. We are going to recap some of the competitive aspects of both Viavi and Cisco.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page